175 related articles for article (PubMed ID: 14534524)
1. Gly389Arg polymorphism of beta1-adrenergic receptor is associated with the cardiovascular response to metoprolol.
Liu J; Liu ZQ; Tan ZR; Chen XP; Wang LS; Zhou G; Zhou HH
Clin Pharmacol Ther; 2003 Oct; 74(4):372-9. PubMed ID: 14534524
[TBL] [Abstract][Full Text] [Related]
2. The Arg389Gly beta1-adrenoceptor polymorphism and catecholamine effects on plasma-renin activity.
Bruck H; Leineweber K; Temme T; Weber M; Heusch G; Philipp T; Brodde OE
J Am Coll Cardiol; 2005 Dec; 46(11):2111-5. PubMed ID: 16325050
[TBL] [Abstract][Full Text] [Related]
3. beta-Adrenergic receptor polymorphisms and responses during titration of metoprolol controlled release/extended release in heart failure.
Terra SG; Pauly DF; Lee CR; Patterson JH; Adams KF; Schofield RS; Belgado BS; Hamilton KK; Aranda JM; Hill JA; Yarandi HN; Walker JR; Phillips MS; Gelfand CA; Johnson JA
Clin Pharmacol Ther; 2005 Mar; 77(3):127-37. PubMed ID: 15735607
[TBL] [Abstract][Full Text] [Related]
4. Beta1-adrenergic receptor polymorphisms and clinical efficacy of betaxolol hydrochloride in normal volunteers.
Schwartz SG; Puckett BJ; Allen RC; Castillo IG; Leffler CT
Ophthalmology; 2005 Dec; 112(12):2131-6. PubMed ID: 16325708
[TBL] [Abstract][Full Text] [Related]
5. Beta 1-adrenergic receptor polymorphisms and antihypertensive response to metoprolol.
Johnson JA; Zineh I; Puckett BJ; McGorray SP; Yarandi HN; Pauly DF
Clin Pharmacol Ther; 2003 Jul; 74(1):44-52. PubMed ID: 12844134
[TBL] [Abstract][Full Text] [Related]
6. Gender-related effects on metoprolol pharmacokinetics and pharmacodynamics in healthy volunteers.
Luzier AB; Killian A; Wilton JH; Wilson MF; Forrest A; Kazierad DJ
Clin Pharmacol Ther; 1999 Dec; 66(6):594-601. PubMed ID: 10613615
[TBL] [Abstract][Full Text] [Related]
7. The gain-of-function G389R variant of the beta1-adrenoceptor does not influence blood pressure or heart rate response to beta-blockade in hypertensive subjects.
O'Shaughnessy KM; Fu B; Dickerson C; Thurston D; Brown MJ
Clin Sci (Lond); 2000 Sep; 99(3):233-8. PubMed ID: 11787477
[TBL] [Abstract][Full Text] [Related]
8. Modifying effects of the R389G beta1-adrenoceptor polymorphism on resting heart rate and blood pressure in patients with obstructive sleep apnoea.
Börgel J; Schulz T; Bartels NK; Epplen JT; Büchner N; Rump LC; Huesing A; Sanner BM; Mügge A
Clin Sci (Lond); 2006 Jan; 110(1):117-23. PubMed ID: 16122377
[TBL] [Abstract][Full Text] [Related]
9. Impact of the ultrarapid metabolizer genotype of cytochrome P450 2D6 on metoprolol pharmacokinetics and pharmacodynamics.
Kirchheiner J; Heesch C; Bauer S; Meisel C; Seringer A; Goldammer M; Tzvetkov M; Meineke I; Roots I; Brockmöller J
Clin Pharmacol Ther; 2004 Oct; 76(4):302-12. PubMed ID: 15470329
[TBL] [Abstract][Full Text] [Related]
10. In-vivo studies do not support a major functional role for the Gly389Arg beta 1-adrenoceptor polymorphism in humans.
Büscher R; Belger H; Eilmes KJ; Tellkamp R; Radke J; Dhein S; Hoyer PF; Michel MC; Insel PA; Brodde OE
Pharmacogenetics; 2001 Apr; 11(3):199-205. PubMed ID: 11337935
[TBL] [Abstract][Full Text] [Related]
11. Age and responses to isometric exercise in hypertension: possible predictors of the antihypertensive effect of diuretics and beta-blockers.
Corea L; Valori C; Bentivoglio M; Verdecchia P; Bichisao E
Int J Clin Pharmacol Ther Toxicol; 1985 Oct; 23(10):554-9. PubMed ID: 2866164
[TBL] [Abstract][Full Text] [Related]
12. [Acute effects of metoprolol on blood pressure and heart rate. Value of the nitroglycerin test].
Chaignon M; Lucsko M; Aubert P; Guédon J
Arch Mal Coeur Vaiss; 1982 Sep; 75(9):963-9. PubMed ID: 6128964
[TBL] [Abstract][Full Text] [Related]
13. Effects of polymorphisms in beta1-adrenoceptor and alpha-subunit of G protein on heart rate and blood pressure during exercise test. The Finnish Cardiovascular Study.
Nieminen T; Lehtimäki T; Laiho J; Rontu R; Niemelä K; Kööbi T; Lehtinen R; Viik J; Turjanmaa V; Kähönen M
J Appl Physiol (1985); 2006 Feb; 100(2):507-11. PubMed ID: 16210433
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and CYP2D6 genotypes do not predict metoprolol adverse events or efficacy in hypertension.
Zineh I; Beitelshees AL; Gaedigk A; Walker JR; Pauly DF; Eberst K; Leeder JS; Phillips MS; Gelfand CA; Johnson JA
Clin Pharmacol Ther; 2004 Dec; 76(6):536-44. PubMed ID: 15592325
[TBL] [Abstract][Full Text] [Related]
15. Beta 1-adrenergic receptor polymorphisms confer differential function and predisposition to heart failure.
Mialet Perez J; Rathz DA; Petrashevskaya NN; Hahn HS; Wagoner LE; Schwartz A; Dorn GW; Liggett SB
Nat Med; 2003 Oct; 9(10):1300-5. PubMed ID: 14502278
[TBL] [Abstract][Full Text] [Related]
16. Effects of common polymorphisms in the alpha1A-, alpha2B-, beta1- and beta2-adrenoreceptors on haemodynamic responses to adrenaline.
Snapir A; Koskenvuo J; Toikka J; Orho-Melander M; Hinkka S; Saraste M; Hartiala J; Scheinin M
Clin Sci (Lond); 2003 May; 104(5):509-20. PubMed ID: 12519093
[TBL] [Abstract][Full Text] [Related]
17. Arg389Gly polymorphism of the human beta1-adrenergic receptor in patients with nonfatal acute myocardial infarction.
Iwai C; Akita H; Kanazawa K; Shiga N; Terashima M; Matsuda Y; Takai E; Miyamoto Y; Shimizu M; Kajiya T; Hayashi T; Yokoyama M
Am Heart J; 2003 Jul; 146(1):106-9. PubMed ID: 12851615
[TBL] [Abstract][Full Text] [Related]
18. The Arg16/Gly beta2-adrenergic receptor polymorphism is associated with altered cardiovascular responses to isometric exercise.
Eisenach JH; McGuire AM; Schwingler RM; Turner ST; Joyner MJ
Physiol Genomics; 2004 Feb; 16(3):323-8. PubMed ID: 14665698
[TBL] [Abstract][Full Text] [Related]
19. A common beta1-adrenergic receptor polymorphism (Arg389Gly) affects blood pressure response to beta-blockade.
Sofowora GG; Dishy V; Muszkat M; Xie HG; Kim RB; Harris PA; Prasad HC; Byrne DW; Nair UB; Wood AJ; Stein CM
Clin Pharmacol Ther; 2003 Apr; 73(4):366-71. PubMed ID: 12709726
[TBL] [Abstract][Full Text] [Related]
20. Impact of CYP2D6 genotype on adverse effects during treatment with metoprolol: a prospective clinical study.
Fux R; Mörike K; Pröhmer AM; Delabar U; Schwab M; Schaeffeler E; Lorenz G; Gleiter CH; Eichelbaum M; Kivistö KT
Clin Pharmacol Ther; 2005 Oct; 78(4):378-87. PubMed ID: 16198657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
